Skip to main content

Drug-Induced Lupus is Rare with TNF inhibitor Therapy

Drug-induced lupus (DIL) has been associated with all TNF inhibitors. Early rates suggested this may be between 0.04 - 0.06 events per 100 patient-years or roughtly 5 per 1000 patient-years. Jani and coworkers presented their analysis of the BSRBR biologics registry presented at the annual British Society of Rheumatology meeting. They found being female, non-white and having higher disease activity were predictive factors for DIL with TNFi. Cutaneous lupus manifestations were common. The found a 3-fold higher risk for patients on TNFi, with a crude event rate of 10 per 10,000 patient years (versus 3 per 10,000 PY on DMARDs alone). 

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

Disclosures
The author has no conflicts of interest to disclose related to this subject